Skip to main content
. 2022 Jun 29;14(7):1381. doi: 10.3390/pharmaceutics14071381

Figure 7.

Figure 7

ADCC activity induced by anti-EGFR/PD-L1 BsAbs. ADCC activity was determined by ADCC Reporter Bioassay. Target cancer cells MDA-MB-468 (A) and MDA-MB-231 (B) were seeded in 96-well plates and incubated with serially diluted antibodies and effector cells for 5–6 h. Bio-Glo™ Luciferase Assay Reagent was added to the plates and luminescence was measured using GloMax discover plate reader.